Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.

about

Artificial Organs 2015: A Year in Review.

P2860

Q38762037-4D6DE453-01F9-424E-9404-98BF9579D251

P2860

Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.

Item

http://www.wikidata.org/entity/Q48071894

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.

@en

Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.

@nl

type

Item

label

Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.

@en

Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.

@nl

prefLabel

Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.

@en

Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.

@nl

P1476

Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.

@en

P2093

Andrea Herrmann

http://www.w3.org/2001/XMLSchema#string

Caroline Schultheiß

http://www.w3.org/2001/XMLSchema#string

René Weischenberg

http://www.w3.org/2001/XMLSchema#string

Roland M Schmid

http://www.w3.org/2001/XMLSchema#string

Wolfgang Huber

http://www.w3.org/2001/XMLSchema#string

Wolfgang Reindl

http://www.w3.org/2001/XMLSchema#string

P2860

Selective leukocyte apheresis for the treatment of inflammatory bowel disease.

Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis

Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.

Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study.

Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease.

A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.

Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis.

Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study.

P304

187-192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AOR.12329

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bernhard Haller

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24981894

http://www.w3.org/2001/XMLSchema#string

Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.

about

P2860

P2860

Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698